קסאלקורי 250 מג 이스라엘 - 히브리어 - Ministry of Health

קסאלקורי 250 מג

pfizer pharmaceuticals israel ltd - crizotinib - קפסולות - crizotinib 250 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive.

קסאלקורי 250 מג 이스라엘 - 히브리어 - Ministry of Health

קסאלקורי 250 מג

pfizer pharmaceuticals israel ltd - crizotinib - קפסולות - crizotinib 250 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive.

אינלייטה 1 מג 이스라엘 - 히브리어 - Ministry of Health

אינלייטה 1 מג

pfizer pharmaceuticals israel ltd - axitinib - טבליות מצופות פילם - axitinib 1 mg - axitinib - axitinib - for the treatment of advanced renal cell carcinoma (rcc) after failure of one prior systemic therapy.

אינלייטה 5 מג 이스라엘 - 히브리어 - Ministry of Health

אינלייטה 5 מג

pfizer pharmaceuticals israel ltd - axitinib - טבליות מצופות פילם - axitinib 5 mg - axitinib - axitinib - for the treatment of advanced renal cell carcinoma (rcc) after failure of one prior systemic therapy.

ארומזין 이스라엘 - 히브리어 - Ministry of Health

ארומזין

pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.

ליריקה 50 מג 이스라엘 - 히브리어 - Ministry of Health

ליריקה 50 מג

pfizer pfe pharmaceuticals israel ltd - pregabalin - קפסולות - pregabalin 50 mg - pregabalin - pregabalin - lyrica is indicated for the treatment of peripheral and central neuropathic pain in adults. management of fibromyalgia.

ליריקה 75 מג 이스라엘 - 히브리어 - Ministry of Health

ליריקה 75 מג

pfizer pfe pharmaceuticals israel ltd - pregabalin - קפסולות - pregabalin 75 mg - pregabalin - pregabalin - lyrica is indicated for the treatment of peripheral and central neuropathic pain in adults. management of fibromyalgia.

ליריקה 100 מג 이스라엘 - 히브리어 - Ministry of Health

ליריקה 100 מג

pfizer pfe pharmaceuticals israel ltd - pregabalin - קפסולות - pregabalin 100 mg - pregabalin - pregabalin - lyrica is indicated for the treatment of peripheral and central neuropathic pain in adults. management of fibromyalgia.

ליריקה 150 מג 이스라엘 - 히브리어 - Ministry of Health

ליריקה 150 מג

pfizer pfe pharmaceuticals israel ltd - pregabalin - קפסולות - pregabalin 150 mg - pregabalin - pregabalin - lyrica is indicated for the treatment of peripheral and central neuropathic pain in adults. management of fibromyalgia.

ליריקה 200 מג 이스라엘 - 히브리어 - Ministry of Health

ליריקה 200 מג

pfizer pfe pharmaceuticals israel ltd - pregabalin - קפסולות - pregabalin 200 mg - pregabalin - pregabalin - lyrica is indicated for the treatment of peripheral and central neuropathic pain in adults. management of fibromyalgia.